收费全文 | 96798篇 |
免费 | 6605篇 |
国内免费 | 511篇 |
耳鼻咽喉 | 1207篇 |
儿科学 | 2286篇 |
妇产科学 | 1384篇 |
基础医学 | 12436篇 |
口腔科学 | 2310篇 |
临床医学 | 9536篇 |
内科学 | 21332篇 |
皮肤病学 | 1517篇 |
神经病学 | 9228篇 |
特种医学 | 3951篇 |
外国民族医学 | 1篇 |
外科学 | 16058篇 |
综合类 | 800篇 |
一般理论 | 194篇 |
预防医学 | 6549篇 |
眼科学 | 1833篇 |
药学 | 5857篇 |
中国医学 | 139篇 |
肿瘤学 | 7296篇 |
2023年 | 864篇 |
2022年 | 1498篇 |
2021年 | 3285篇 |
2020年 | 1820篇 |
2019年 | 2822篇 |
2018年 | 3317篇 |
2017年 | 2350篇 |
2016年 | 2541篇 |
2015年 | 2854篇 |
2014年 | 3941篇 |
2013年 | 5047篇 |
2012年 | 7638篇 |
2011年 | 7738篇 |
2010年 | 4266篇 |
2009年 | 3702篇 |
2008年 | 6370篇 |
2007年 | 6141篇 |
2006年 | 5950篇 |
2005年 | 5868篇 |
2004年 | 5280篇 |
2003年 | 4845篇 |
2002年 | 4351篇 |
2001年 | 619篇 |
2000年 | 488篇 |
1999年 | 684篇 |
1998年 | 891篇 |
1997年 | 710篇 |
1996年 | 573篇 |
1995年 | 565篇 |
1994年 | 451篇 |
1993年 | 459篇 |
1992年 | 364篇 |
1991年 | 324篇 |
1990年 | 298篇 |
1989年 | 289篇 |
1988年 | 293篇 |
1987年 | 266篇 |
1986年 | 291篇 |
1985年 | 287篇 |
1984年 | 356篇 |
1983年 | 308篇 |
1982年 | 339篇 |
1981年 | 338篇 |
1980年 | 263篇 |
1979年 | 151篇 |
1978年 | 193篇 |
1977年 | 181篇 |
1976年 | 130篇 |
1975年 | 134篇 |
1974年 | 132篇 |
Objective In a pilot retrospective cohort, to determine the relationship between the use of COX inhibitors and the incidence, recurrence, and metastases of melanoma in high-risk patients.
Methods Reviewing computerized records at the Miami Veterans Affairs Medical Center, we retrospectively examined the association between COX inhibitor use and melanoma incidence, recurrence, and metastases in high-risk subjects: white subjects previously diagnosed with melanoma (1996–2003). We evaluated three potential outcomes: new melanoma diagnosis, recurrence of a previous melanoma, and melanoma metastasis.
Results Eighty-three subjects with melanoma were included. There was one metastasis among 28 subjects prescribed COX inhibitors, whereas four new melanomas (7.3%), two melanoma recurrences, and six metastases (10.9%) occurred among 55 patients not prescribed COX inhibitors. Although no individual outcomes measures reached statistical significance, combining the three measures, these were significantly lower in users of COX inhibitors compared with nonusers (1 vs 12; p = .05 ). After adjustment for age and tumor depth of invasion, COX inhibitor users had significantly lower rates of melanoma outcome measures (odds ratio 0.08; 95% confidence interval 0.01–0.77; p = .03 ).
Conclusion Potential exists for chemoprevention of melanoma among high-risk patients. 相似文献
Methods: Forty patients scheduled to undergo laparoscopic colectomy were randomly allocated to receive intravenous lidocaine (bolus injection of 1.5 mg/kg lidocaine at induction of anesthesia, then a continuous infusion of 2 mg [middle dot] kg-1 [middle dot] h-1 intraoperatively and 1.33 mg [middle dot] kg-1 [middle dot] h-1 for 24 h postoperatively) or an equal volume of saline. All patients received similar intensive postoperative rehabilitation. Postoperative pain scores, opioid consumption, and fatigue scores were measured. Times to first flatus, defecation, and hospital discharge were recorded. Postoperative endocrine (cortisol and catecholamines) and metabolic (leukocytes, C-reactive protein, and glucose) responses were measured for 48 h. Data (presented as median [25-75% interquartile range], lidocaine vs. saline groups) were analyzed using Mann-Whitney tests. P < 0.05 was considered statistically significant.
Results: Patient demographics were similar in the two groups. Times to first flatus (17 [11-24] vs. 28 [25-33] h; P < 0.001), defecation (28 [24-37] vs. 51 [41-70] h; P = 0.001), and hospital discharge (2 [2-3] vs. 3 [3-4] days; P = 0.001) were significantly shorter in patients who received lidocaine. Lidocaine significantly reduced opioid consumption (8 [5-18] vs. 22 [14-36] mg; P = 0.005) and postoperative pain and fatigue scores. In contrast, endocrine and metabolic responses were similar in the two groups. 相似文献